| Revenue growth | 20% YoY for FY26; 25% YoY for Q4 FY26. |
|---|---|
| Margins | Consolidated FY26 margin 24.2%; mature hospital margins stable at 24.4%. |
| Demand visibility | Strong momentum across network; high demand for tertiary care in UP/Bihar. |
| Management confidence | High confidence in 24-25% mature margins and Noida ramp-up. |
Growth
Total income grew 20% YoY; EBITDA (ex-Noida) rose 19% to ₹11,343 million; Inpatient counts increased 16%.
Outlook
Capex of ₹45,000 million planned over 5 years; addition of 2,700 beds via greenfield projects; targeting breakeven for Noida in FY27.
Risks
Early-stage operating losses at Noida facility; doctor attrition risks from new competitor hospitals in Gurgaon; geopolitical challenges in Middle East.
Earnings Call filed with BSE, NSE: MEDANTA. Summary written with AI assistance from the document.
Global Health Ltd: key numbers
- Share price
- ₹1,293.80
- Market cap
- ₹34,787 Cr
- Revenue (annual)
- ₹4,410 Cr
- Net profit (annual)
- ₹556.5 Cr
- P/E (TTM)
- 62.5×Sector 53.1×
- Promoter holding
- 33.00%-0.01% QoQ
- FII holding
- 9.46%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from Global Health Ltd
All →Global Health Employee Stock Options
Global Health Limited has allotted equity shares under its ESOP/ESPS scheme. This action results in a minor increase in the company's total paid-up share capital.
Global Health Employee Stock Options
Global Health Limited has allotted 3,000 equity shares under its employee stock option plan at a premium of Rs. 1,498 per share.
- Value
- ₹0.45 Cr
Global Health Annual General Meeting
Global Health Limited held its 22nd Annual General Meeting on September 16, 2026. The meeting covered financial statement adoption and shareholder dividend declaration.
Global Health Other Announcement
Global Health Limited has filed its Business Responsibility and Sustainability Report for the financial year 2025-26 as mandated by SEBI (LODR) regulations.
Global Health Annual General Meeting
Global Health Limited has announced its 22nd Annual General Meeting to be held on September 16, 2026, to consider financial statements, dividends, and director re-appointment.
- Value
- ₹0.12 Cr
Global Health Annual Report
Global Health Limited has submitted its Annual Report for the financial year 2025-26, alongside the notice for its 22nd Annual General Meeting.